Product Information
CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB is a generic product labeled by Sandoz Inc., priced at $0.7867 per EA under NDC 00781566901. Its NADAC has been published 619 times since Aug 20, 2014.
Strength
50; 200; 200 mg/1; mg/1; mg/1
Manufacturer
Sandoz Inc.NDC
00781566901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; ENTACAPONE; LEVODOPAApproval Type
Authorized Generic (NDA)
FDA Application
NDA021485On Market Since
6/18/2014
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB has been published 619 times since Aug 20, 2014, and over the history we have for it it has declined 69.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7867 per EA |
|---|---|
| All-time high | $2.6890 (Oct 15, 2014) |
| All-time low | $0.6636 (Aug 21, 2024) |
| 52-week high | $0.7867 |
| 52-week low | $0.7094 |
| Median price | $0.9887 |
| Average price | $1.2717 |
| Largest weekly change | +54.1% (Jun 23, 2021) |
| Weeks tracked | 619 |
| Tracking since | Aug 20, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Carbidopa, Levodopa, and Entacapone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB, manufactured by Sandoz Inc., is $0.7867 per EA (NDC 00781566901), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB has declined 69.3%. It has been tracked across 619 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB?
Since Aug 20, 2014, the NADAC for CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB has ranged from a low of $0.6636 (Aug 21, 2024) to a high of $2.6890 (Oct 15, 2014), with a median of $0.9887 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB?
CARBIDOPA-LEVODOPA-ENTACAPONE 50-200-200 MG TAB (NDC 00781566901) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification